HUE052677T2 - Antigén és eljárás annak elõállítására - Google Patents
Antigén és eljárás annak elõállításáraInfo
- Publication number
- HUE052677T2 HUE052677T2 HUE14776600A HUE14776600A HUE052677T2 HU E052677 T2 HUE052677 T2 HU E052677T2 HU E14776600 A HUE14776600 A HU E14776600A HU E14776600 A HUE14776600 A HU E14776600A HU E052677 T2 HUE052677 T2 HU E052677T2
- Authority
- HU
- Hungary
- Prior art keywords
- antigen
- production
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1351057 | 2013-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE052677T2 true HUE052677T2 (hu) | 2021-05-28 |
Family
ID=51626006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14776600A HUE052677T2 (hu) | 2013-09-13 | 2014-09-12 | Antigén és eljárás annak elõállítására |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10159729B2 (hu) |
| EP (1) | EP3043814B1 (hu) |
| HU (1) | HUE052677T2 (hu) |
| LT (1) | LT3043814T (hu) |
| PL (1) | PL3043814T3 (hu) |
| SI (1) | SI3043814T1 (hu) |
| WO (1) | WO2015036549A1 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2745834B1 (en) * | 2012-12-18 | 2016-09-28 | Jens Frauenfeld | Salipro particles |
| EP3043814B1 (en) | 2013-09-13 | 2020-12-02 | Salipro Biotech AB | Antigen and method for production thereof |
| EP3284460A1 (en) | 2016-08-19 | 2018-02-21 | Salipro Biotech AG | Saposin lipoprotein particles and libraries from crude membranes |
| AU2018331357A1 (en) | 2017-09-18 | 2020-04-02 | Bayer Healthcare Llc | Methods of inactivation of viruses using N-methylglucamides and its Derivatives |
| EP3725304A1 (en) | 2019-04-15 | 2020-10-21 | Salipro Biotech AB | Production of salipro particles |
| CN110564734A (zh) * | 2019-09-28 | 2019-12-13 | 中国医学科学院病原生物学研究所 | 一种埃及血吸虫重组融合蛋白ShSAP及其在血吸虫病免疫诊断中的应用 |
| WO2022090752A1 (en) * | 2020-10-26 | 2022-05-05 | Pécsi Tudományegyetem | Vaccine platform |
| WO2023001912A1 (en) | 2021-07-22 | 2023-01-26 | Salipro Biotech AB | Methods for structure determination and drug design using salipro particles |
| EP4123307A1 (en) | 2021-07-22 | 2023-01-25 | Salipro Biotech AB | Methods for structure determination and drug design using salipro particles |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5652339A (en) | 1993-12-31 | 1997-07-29 | Rotkreuzstiftung Zentrallaboratorium | Method of producing reconstituted lipoproteins |
| US20020177551A1 (en) | 2000-05-31 | 2002-11-28 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
| US7083958B2 (en) | 2000-11-20 | 2006-08-01 | The Board Of Trustees Of The University Of Illinois | Membrane scaffold proteins |
| CN1474831A (zh) | 2000-11-20 | 2004-02-11 | ����ŵ˹������ѧ�йܻ� | 膜支架蛋白 |
| US7622437B2 (en) | 2000-11-20 | 2009-11-24 | The Board Of Trustees Of The University Of Illinois | Tissue factor compositions and methods |
| US7592008B2 (en) | 2000-11-20 | 2009-09-22 | The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois | Membrane scaffold proteins |
| CA2515892C (en) | 2003-02-14 | 2012-10-23 | Children's Hospital & Research Center At Oakland | Lipophilic drug delivery vehicle and methods of use thereof |
| US7834147B2 (en) | 2003-04-28 | 2010-11-16 | Childrens Hospital Medical Center | Saposin C-DOPS: a novel anti-tumor agent |
| EP1677763A1 (en) | 2003-10-01 | 2006-07-12 | Children's Hospital & Research Center at Oakland | Lipophilic drug delivery vehicle and methods of use thereof |
| US20070117179A1 (en) | 2005-09-27 | 2007-05-24 | Invitrogen Corporation | In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles |
| WO2008051818A2 (en) | 2006-10-20 | 2008-05-02 | Children's Hospital Medical Center | Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| EP2118129A4 (en) | 2007-03-01 | 2010-04-28 | Life Technologies Corp | ISOLATED PHOSPHOLIPID PROTEIN PARTICLES |
| US8999320B2 (en) | 2008-01-30 | 2015-04-07 | The Rockefeller University | Nanoscale bound bilayers, methods of use and production |
| WO2010053489A1 (en) | 2008-11-07 | 2010-05-14 | Children's Hospital Medical Center | Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
| US10525152B2 (en) | 2009-10-09 | 2020-01-07 | Signablok, Inc. | Methods and compositions for targeted imaging |
| US20120190609A1 (en) | 2010-08-30 | 2012-07-26 | Martin Bader | Method for producing a lipid particle, the lipid particle itself and its use |
| US9585972B2 (en) | 2011-05-09 | 2017-03-07 | Sherry L. Thornton | Method for imaging a site of arthritis in an animal |
| EP3043814B1 (en) | 2013-09-13 | 2020-12-02 | Salipro Biotech AB | Antigen and method for production thereof |
-
2014
- 2014-09-12 EP EP14776600.0A patent/EP3043814B1/en active Active
- 2014-09-12 PL PL14776600T patent/PL3043814T3/pl unknown
- 2014-09-12 LT LTEP14776600.0T patent/LT3043814T/lt unknown
- 2014-09-12 WO PCT/EP2014/069512 patent/WO2015036549A1/en active Application Filing
- 2014-09-12 HU HUE14776600A patent/HUE052677T2/hu unknown
- 2014-09-12 US US15/021,346 patent/US10159729B2/en active Active
- 2014-09-12 SI SI201431770T patent/SI3043814T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20160220664A1 (en) | 2016-08-04 |
| SI3043814T1 (sl) | 2021-04-30 |
| PL3043814T3 (pl) | 2021-05-17 |
| EP3043814B1 (en) | 2020-12-02 |
| EP3043814A1 (en) | 2016-07-20 |
| US10159729B2 (en) | 2018-12-25 |
| WO2015036549A1 (en) | 2015-03-19 |
| LT3043814T (lt) | 2021-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291446A (en) | Anti-trop2 antibodies and methods for their production | |
| HUE054605T2 (hu) | Retenciós készülék, valamint eljárás az elõállítására | |
| EP3006415B8 (en) | Method for producing nanocement and nanocement | |
| EP2987649A4 (en) | TIRES AND METHOD FOR THE PRODUCTION OF TIRES | |
| EP2987650A4 (en) | TIRE AND METHOD FOR PRODUCING THE SAME | |
| PL3043814T3 (pl) | Antygen i sposób jego wytwarzania | |
| EP3045770A4 (en) | FLAT RIBBON AND MANUFACTURING METHOD THEREFOR | |
| GB201315777D0 (en) | Novel method | |
| IL239689A0 (en) | A method for producing antibodies | |
| EP2960338A4 (en) | SUGAR SOLUTION PROCESS | |
| HK1218893A1 (zh) | 蛋白質的生產方法 | |
| GB201301857D0 (en) | Method | |
| EP2868476A4 (en) | PROCESS FOR PRODUCING PRINTED MEDIA | |
| EP2952895A4 (en) | PROCESS FOR PRODUCING A MARKED ANTIBODY | |
| EP2944375A4 (en) | PRODUCTION OF MICROCAPSULE AND MICROCAPSULE | |
| IL241779A0 (en) | Method for protein production | |
| PL3069610T3 (pl) | Ko-kryształ i sposób jego wytwarzania | |
| GB201305714D0 (en) | Method | |
| GB201301233D0 (en) | Method | |
| GB201300409D0 (en) | Method | |
| GB201310151D0 (en) | Novel method | |
| GB201301094D0 (en) | Method | |
| IL242505B (en) | Method for producing specific oximes and oximethers | |
| GB201301384D0 (en) | Method for antibody production | |
| EP2987780A4 (en) | POLYOL ETHER COMPOUND AND PROCESS FOR PRODUCING THE SAME |